ロード中...
Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
It has been revealed by our previous proteomic study that the expression profile is different between well-differentiated and poorly differentiated hepatocellular carcinoma (HCC). Among those differently expressed proteins, peroxiredoxin2 (PRDX2) was our protein of interest. The present study aimed...
保存先:
| 出版年: | Oncol Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6365706/ https://ncbi.nlm.nih.gov/pubmed/30747220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.6977 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|